Immunology

J.G. Bodmer, S.G.E. Marsh, E.D. Albert, W.F. Bodmer, B. Dupont, H.A. Erlich, B. Mach, W.R. Mayr, P. Parham, T. Sasazuki, G.M.Th. Schreuder, J.L. Strominger, A. Svej-gaard, P.I. Terasaki, "Nomenclature for factors of the HLA system, 1991," Tissue Antigens, 39:161-73, 1992. Julia G. Bodmer (Tissue Antigen Laboratory, Imperial Cancer Research Fund, London): "`The dull catalogue of common things.' These words of the 19th-century English

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Julia G. Bodmer (Tissue Antigen Laboratory, Imperial Cancer Research Fund, London): "`The dull catalogue of common things.' These words of the 19th-century English poet John Keats would sound like an apt description of a nomenclature report. Yet for the second time in three years an HLA nomenclature report has been selected as a hot paper (see Hot Papers, The Scientist, March 18, 1991, page 15). To draw an analogy, the columns of figures in a company report look utterly boring to the uninitiated, but to the cognoscenti they tell the story of the company as enthrallingly as any thriller. Thus it is with nomenclature reports. In the dry tables and lists of names of new genes and alleles we can trace the progress of the field.

"The acceleration of progress can be measured by the number of new genes and alleles identified since the last report-- 35 genes and 275 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies